Abstract
SUMMARY If gestational diabetes mellitus (GDM) is not recognized and treated, it has a negative impact on maternal and fetal health. No general consensus on how best to screen for and diagnose this disease has been established to date. The Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) study and two randomized trials on the treatment of mild GDM have confirmed the close relationship between maternal glycemia and perinatal outcome. In the light of these findings, new recommendations have recently been formulated by the International Association of Diabetes and Pregnancy Study Groups (IADPSG), also concerning the diagnosis of overt diabetes early in pregnancy and routine screening for GDM at 24 gestational weeks with a 75 g oral glucose tolerance test, considering even only one higher than normal value sufficient for a diagnosis of GDM. Here we discuss the possible impact of these new recommendations on the treatment of GDM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
